GAVI facts and figures

in page functions
[French]

Statistics measuring the GAVI Alliance's impact on global immunisation

Every year, academics, journalists, teachers and students ask for statistics detailing GAVI's results since the Alliance was established in 2000. Sourcing the GAVI Secretariat and members of the Alliance, including WHO, UNICEF and civil society organisations, these key facts and figures list GAVI's achievements to date as well as demonstrating the Alliance's catalytic role within global immunisation.

168 million

GAVI-supported vaccine campaigns have resulted in 100 million individuals being immunised against meningitis A and 68 million against yellow fever since 2000.

Source: Meningitis A Conjugate Vaccine Immunizaton Campaign. Joint WHO/UNICEF 2011 Progress Report: January to December 2012. March 2013, p.3 | 2011 data. Yellow Fever Initiative. Joint WHO and UNICEF 2011 Progress Report Nov 2012, p.13, 15. 2012 data: Based on data from Epidemiology of Yellow Fever in the African Region: 2012 report. WHO Regional Office for Africa. April 2013, p.6.

64

As of the end of August, 64 out of the 67 co-financing countries had fulfilled their commitments for 2012.

Source: GAVI Alliance

> 70

GAVI has provided funding to strengthen health systems and immunisation services in more than 70 countries.

Source: GAVI Alliance

70%

70% of cervical cancer cases can be prevented with human papillomavirus vaccines.

Source: World Health Organization

6 million

Approximately six million future deaths averted from hepatitis B, Haemophilus influenzae type B, measles, pertussis, pneumococcal disease, polio, rotavirus diarrhoea and yellow fever since GAVI's launch in 2000.

Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, as of October 2013

440 million

Since 2000, 440 million additional children have been immunised through GAVI support to routine immunisation in the world's poorest countries.

Source: WHO-UNICEF 2013

10 million

It is estimated that over 10 million children have been immunised against pneumococcal disease with GAVI support by the end of 2012.

Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, as of October 2012

+243,000,000

GAVI support will assist countries to immunise a further 243 million children from 2011 to 2015.

Source: GAVI Alliance

73 countries

GAVI supports the 73 poorest countries in the world.

Source: GAVI Alliance

US$ 8.4 billion

By 31 August 2013, GAVI had committed US$ 8.4 billion in programme support until 2016 to the world’s poorest countries.

Source: GAVI Alliance, 30 April 2013

4 million

GAVI's support for vaccines through to 2015 will contribute to averting close to an additional four million future deaths.

Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, as of October 2012

39%

Over the course of a decade, the weighted average price of pentavalent vaccine dropped by 39% from US$ 3.56 in 2003 to US$ 2.17 per dose in 2012, with a lowest ever price of US$ 1.19 per dose from one supplier in 2013.

Source: GAVI Alliance 2013

1 in 5

1 in 5 of all children who die before the age of five lose their lives to vaccine-preventable diseases.

Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, as of October 2012

5 -> 12

2001: 5 vaccine suppliers to GAVI (1 in an emerging market) | mid-2013: 12 vaccine suppliers to GAVI (over half now based in Africa, Asia, Latin America)

Source: UNICEF Supply Division, 2012

22 million

Over 22 million infants remain unimmunised in the world each year.

Source: WHO/UNICEF

close icon

modal window here